Talkspace PE Ratio 2020-2025 | TALK
Current and historical p/e ratio for Talkspace (TALK) from 2020 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Talkspace PE ratio as of June 12, 2025 is 150.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Talkspace PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-13 | 2.85 | 142.50 | |
| 2025-03-31 | 2.56 | $0.02 | 128.00 |
| 2024-12-31 | 3.09 | $0.01 | 309.00 |
| 2024-09-30 | 2.09 | $-0.01 | 0.00 |
| 2024-06-30 | 2.30 | $-0.05 | 0.00 |
| 2024-03-31 | 3.57 | $-0.08 | 0.00 |
| 2023-12-31 | 2.54 | $-0.12 | 0.00 |
| 2023-09-30 | 1.95 | $-0.22 | 0.00 |
| 2023-06-30 | 1.27 | $-0.30 | 0.00 |
| 2023-03-31 | 0.70 | $-0.42 | 0.00 |
| 2022-12-31 | 0.61 | $-0.50 | 0.00 |
| 2022-09-30 | 1.03 | $-0.53 | 0.00 |
| 2022-06-30 | 1.70 | $-0.41 | 0.00 |
| 2022-03-31 | 1.74 | $-1.41 | 0.00 |
| 2021-12-31 | 1.97 | $-1.28 | 0.00 |
| 2021-09-30 | 3.65 | $-1.14 | 0.00 |
| 2021-06-30 | 8.31 | $-1.15 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.502B | $0.188B |
| Talkspace Inc. is a virtual behavioral healthcare company. It delivered services through an easy-to-use and fully encrypted web and mobile platform, consistent with HIPAA and other state regulatory requirements. The company offers treatment options for almost every need. Talkspace Inc., formerly known as Hudson Executive Investment Corp., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.108B | 58.66 |
| Hims & Hers Health (HIMS) | United States | $12.792B | 132.91 |
| Tempus AI (TEM) | United States | $12.331B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.644B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.793B | 59.27 |
| Privia Health (PRVA) | United States | $2.768B | 189.17 |
| Hinge Health (HNGE) | United States | $2.732B | 0.00 |
| Enovis (ENOV) | United States | $1.845B | 10.28 |
| Schrodinger (SDGR) | United States | $1.676B | 0.00 |
| Phreesia (PHR) | United States | $1.584B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.491B | 0.00 |
| Omnicell (OMCL) | United States | $1.403B | 24.74 |
| Azenta (AZTA) | United States | $1.392B | 64.70 |
| 10x Genomics (TXG) | United States | $1.303B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.639B | 0.00 |
| Claritev (CTEV) | United States | $0.620B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.603B | 0.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| Outset Medical (OM) | United States | $0.359B | 0.00 |
| TruBridge (TBRG) | United States | $0.357B | 792.33 |
| Health Catalyst (HCAT) | United States | $0.277B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.258B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.193B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Pulmonx (LUNG) | United States | $0.126B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.126B | 0.00 |
| American Well (AMWL) | United States | $0.112B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| CareCloud (CCLD) | United States | $0.091B | 3.48 |
| 111 (YI) | China | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Zhongchao (ZCMD) | China | $0.033B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |